NEW YORK (Reuters Health) – Patients with marked clinical fluctuation in neurologic status due to cerebral ischemia may benefit from thrombolytic therapy, researchers from Canada report in the…
NEW YORK (Reuters Health) For the 5% to 10% of adults who fail to mount an adequate response to the standard hepatitis B virus (HBV) vaccine regimen, a…
NEW YORK (Reuters Health) – A small but significant increase in mortality is seen within 120 days of transrectal ultrasound guided (TRUS) prostate biopsy, according to a report…
NEW YORK (Reuters Health) – Nearly all children with suspected or known hypersensitivity to vaccines can be safely immunized, US researchers contend, and in the September issue of…
NEW YORK (Reuters Health) – The quadrivalent human papillomavirus (HPV) vaccine (Gardasil) carries a higher risk of anaphylaxis than does other commonly administered vaccines, Australian researchers report. Still,…
NEW YORK (Reuters Health) – Data from the Geneva Cancer Registry show an increased long-term risk of colon cancer after external radiation therapy for prostate cancer, according to…
NEW YORK (Reuters Health) – Multislice CT detects proximal coronary atherosclerotic plaque or obstructive coronary artery disease in “a significant proportion” of patients with a low or intermediate…
NEW YORK (Reuters Health) – Finnish researchers report evidence that proliferative diabetic retinopathy, like diabetic nephropathy, clusters in families, suggesting that genetic factors play a role in its…
NEW YORK (Reuters Health) – The Alzheimer’s drug memantine appears to be a useful treatment for binge eating disorder, significantly reducing the frequency and severity of binge episodes,…
NEW YORK (Reuters Health) – Children who develop Crohn’s disease before the age of five years have a less complicated disease course than children with disease onset after…